Report Detail

Pharma & Healthcare Global Animal Genetic Engineering Vaccines Market Growth 2023-2029

  • RnM4519812
  • |
  • 10 March, 2023
  • |
  • Global
  • |
  • 126 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global Animal Genetic Engineering Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Animal Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Animal Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Animal Genetic Engineering Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Animal Genetic Engineering Vaccines players cover Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Animal Genetic Engineering Vaccines Industry Forecast” looks at past sales and reviews total world Animal Genetic Engineering Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Animal Genetic Engineering Vaccines sales for 2023 through 2029. With Animal Genetic Engineering Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Genetic Engineering Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Animal Genetic Engineering Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Genetic Engineering Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Animal Genetic Engineering Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Genetic Engineering Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Genetic Engineering Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal Genetic Engineering Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine

Segmentation by application
Poultry
Livestock
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Santé Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Animal Genetic Engineering Vaccines market?
What factors are driving Animal Genetic Engineering Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal Genetic Engineering Vaccines market opportunities vary by end market size?
How does Animal Genetic Engineering Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Animal Genetic Engineering Vaccines Annual Sales 2018-2029
    • 2.1.2 World Current & Future Analysis for Animal Genetic Engineering Vaccines by Geographic Region, 2018, 2022 & 2029
    • 2.1.3 World Current & Future Analysis for Animal Genetic Engineering Vaccines by Country/Region, 2018, 2022 & 2029
  • 2.2 Animal Genetic Engineering Vaccines Segment by Type
    • 2.2.1 Genetic Recombinant Vaccine
    • 2.2.2 Recombinant Subunit Vaccines
    • 2.2.3 Genetic Vaccine
  • 2.3 Animal Genetic Engineering Vaccines Sales by Type
    • 2.3.1 Global Animal Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
    • 2.3.2 Global Animal Genetic Engineering Vaccines Revenue and Market Share by Type (2018-2023)
    • 2.3.3 Global Animal Genetic Engineering Vaccines Sale Price by Type (2018-2023)
  • 2.4 Animal Genetic Engineering Vaccines Segment by Application
    • 2.4.1 Poultry
    • 2.4.2 Livestock
    • 2.4.3 Other
  • 2.5 Animal Genetic Engineering Vaccines Sales by Application
    • 2.5.1 Global Animal Genetic Engineering Vaccines Sale Market Share by Application (2018-2023)
    • 2.5.2 Global Animal Genetic Engineering Vaccines Revenue and Market Share by Application (2018-2023)
    • 2.5.3 Global Animal Genetic Engineering Vaccines Sale Price by Application (2018-2023)

3 Global Animal Genetic Engineering Vaccines by Company

  • 3.1 Global Animal Genetic Engineering Vaccines Breakdown Data by Company
    • 3.1.1 Global Animal Genetic Engineering Vaccines Annual Sales by Company (2018-2023)
    • 3.1.2 Global Animal Genetic Engineering Vaccines Sales Market Share by Company (2018-2023)
  • 3.2 Global Animal Genetic Engineering Vaccines Annual Revenue by Company (2018-2023)
    • 3.2.1 Global Animal Genetic Engineering Vaccines Revenue by Company (2018-2023)
    • 3.2.2 Global Animal Genetic Engineering Vaccines Revenue Market Share by Company (2018-2023)
  • 3.3 Global Animal Genetic Engineering Vaccines Sale Price by Company
  • 3.4 Key Manufacturers Animal Genetic Engineering Vaccines Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Animal Genetic Engineering Vaccines Product Location Distribution
    • 3.4.2 Players Animal Genetic Engineering Vaccines Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Animal Genetic Engineering Vaccines by Geographic Region

  • 4.1 World Historic Animal Genetic Engineering Vaccines Market Size by Geographic Region (2018-2023)
    • 4.1.1 Global Animal Genetic Engineering Vaccines Annual Sales by Geographic Region (2018-2023)
    • 4.1.2 Global Animal Genetic Engineering Vaccines Annual Revenue by Geographic Region (2018-2023)
  • 4.2 World Historic Animal Genetic Engineering Vaccines Market Size by Country/Region (2018-2023)
    • 4.2.1 Global Animal Genetic Engineering Vaccines Annual Sales by Country/Region (2018-2023)
    • 4.2.2 Global Animal Genetic Engineering Vaccines Annual Revenue by Country/Region (2018-2023)
  • 4.3 Americas Animal Genetic Engineering Vaccines Sales Growth
  • 4.4 APAC Animal Genetic Engineering Vaccines Sales Growth
  • 4.5 Europe Animal Genetic Engineering Vaccines Sales Growth
  • 4.6 Middle East & Africa Animal Genetic Engineering Vaccines Sales Growth

5 Americas

  • 5.1 Americas Animal Genetic Engineering Vaccines Sales by Country
    • 5.1.1 Americas Animal Genetic Engineering Vaccines Sales by Country (2018-2023)
    • 5.1.2 Americas Animal Genetic Engineering Vaccines Revenue by Country (2018-2023)
  • 5.2 Americas Animal Genetic Engineering Vaccines Sales by Type
  • 5.3 Americas Animal Genetic Engineering Vaccines Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Animal Genetic Engineering Vaccines Sales by Region
    • 6.1.1 APAC Animal Genetic Engineering Vaccines Sales by Region (2018-2023)
    • 6.1.2 APAC Animal Genetic Engineering Vaccines Revenue by Region (2018-2023)
  • 6.2 APAC Animal Genetic Engineering Vaccines Sales by Type
  • 6.3 APAC Animal Genetic Engineering Vaccines Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Animal Genetic Engineering Vaccines by Country
    • 7.1.1 Europe Animal Genetic Engineering Vaccines Sales by Country (2018-2023)
    • 7.1.2 Europe Animal Genetic Engineering Vaccines Revenue by Country (2018-2023)
  • 7.2 Europe Animal Genetic Engineering Vaccines Sales by Type
  • 7.3 Europe Animal Genetic Engineering Vaccines Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Animal Genetic Engineering Vaccines by Country
    • 8.1.1 Middle East & Africa Animal Genetic Engineering Vaccines Sales by Country (2018-2023)
    • 8.1.2 Middle East & Africa Animal Genetic Engineering Vaccines Revenue by Country (2018-2023)
  • 8.2 Middle East & Africa Animal Genetic Engineering Vaccines Sales by Type
  • 8.3 Middle East & Africa Animal Genetic Engineering Vaccines Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Animal Genetic Engineering Vaccines
  • 10.3 Manufacturing Process Analysis of Animal Genetic Engineering Vaccines
  • 10.4 Industry Chain Structure of Animal Genetic Engineering Vaccines

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Animal Genetic Engineering Vaccines Distributors
  • 11.3 Animal Genetic Engineering Vaccines Customer

12 World Forecast Review for Animal Genetic Engineering Vaccines by Geographic Region

  • 12.1 Global Animal Genetic Engineering Vaccines Market Size Forecast by Region
    • 12.1.1 Global Animal Genetic Engineering Vaccines Forecast by Region (2024-2029)
    • 12.1.2 Global Animal Genetic Engineering Vaccines Annual Revenue Forecast by Region (2024-2029)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Animal Genetic Engineering Vaccines Forecast by Type
  • 12.7 Global Animal Genetic Engineering Vaccines Forecast by Application

13 Key Players Analysis

  • 13.1 Merck
    • 13.1.1 Merck Company Information
    • 13.1.2 Merck Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.1.3 Merck Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.1.4 Merck Main Business Overview
    • 13.1.5 Merck Latest Developments
  • 13.2 GSK
    • 13.2.1 GSK Company Information
    • 13.2.2 GSK Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.2.3 GSK Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.2.4 GSK Main Business Overview
    • 13.2.5 GSK Latest Developments
  • 13.3 Sanofi
    • 13.3.1 Sanofi Company Information
    • 13.3.2 Sanofi Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.3.3 Sanofi Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.3.4 Sanofi Main Business Overview
    • 13.3.5 Sanofi Latest Developments
  • 13.4 Zoties
    • 13.4.1 Zoties Company Information
    • 13.4.2 Zoties Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.4.3 Zoties Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.4.4 Zoties Main Business Overview
    • 13.4.5 Zoties Latest Developments
  • 13.5 Elanco
    • 13.5.1 Elanco Company Information
    • 13.5.2 Elanco Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.5.3 Elanco Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.5.4 Elanco Main Business Overview
    • 13.5.5 Elanco Latest Developments
  • 13.6 Boehringer Ingelheim
    • 13.6.1 Boehringer Ingelheim Company Information
    • 13.6.2 Boehringer Ingelheim Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.6.3 Boehringer Ingelheim Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.6.4 Boehringer Ingelheim Main Business Overview
    • 13.6.5 Boehringer Ingelheim Latest Developments
  • 13.7 Indian Immunologicals
    • 13.7.1 Indian Immunologicals Company Information
    • 13.7.2 Indian Immunologicals Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.7.3 Indian Immunologicals Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.7.4 Indian Immunologicals Main Business Overview
    • 13.7.5 Indian Immunologicals Latest Developments
  • 13.8 China Animal Husbandry Industry Co.,Ltd.
    • 13.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
    • 13.8.2 China Animal Husbandry Industry Co.,Ltd. Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.8.3 China Animal Husbandry Industry Co.,Ltd. Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.8.4 China Animal Husbandry Industry Co.,Ltd. Main Business Overview
    • 13.8.5 China Animal Husbandry Industry Co.,Ltd. Latest Developments
  • 13.9 Yebio Bioengineering Co., Ltd Of Qingdao
    • 13.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
    • 13.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Main Business Overview
    • 13.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Latest Developments
  • 13.10 Jinyu Bio-technology Co.,ltd.
    • 13.10.1 Jinyu Bio-technology Co.,ltd. Company Information
    • 13.10.2 Jinyu Bio-technology Co.,ltd. Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.10.3 Jinyu Bio-technology Co.,ltd. Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.10.4 Jinyu Bio-technology Co.,ltd. Main Business Overview
    • 13.10.5 Jinyu Bio-technology Co.,ltd. Latest Developments
  • 13.11 HVRI
    • 13.11.1 HVRI Company Information
    • 13.11.2 HVRI Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.11.3 HVRI Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.11.4 HVRI Main Business Overview
    • 13.11.5 HVRI Latest Developments
  • 13.12 Ringpu Biology
    • 13.12.1 Ringpu Biology Company Information
    • 13.12.2 Ringpu Biology Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.12.3 Ringpu Biology Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.12.4 Ringpu Biology Main Business Overview
    • 13.12.5 Ringpu Biology Latest Developments
  • 13.13 Kyoto Biken Laboratories
    • 13.13.1 Kyoto Biken Laboratories Company Information
    • 13.13.2 Kyoto Biken Laboratories Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.13.3 Kyoto Biken Laboratories Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.13.4 Kyoto Biken Laboratories Main Business Overview
    • 13.13.5 Kyoto Biken Laboratories Latest Developments
  • 13.14 FATRO
    • 13.14.1 FATRO Company Information
    • 13.14.2 FATRO Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.14.3 FATRO Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.14.4 FATRO Main Business Overview
    • 13.14.5 FATRO Latest Developments
  • 13.15 Ceva Santé Animale
    • 13.15.1 Ceva Santé Animale Company Information
    • 13.15.2 Ceva Santé Animale Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.15.3 Ceva Santé Animale Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.15.4 Ceva Santé Animale Main Business Overview
    • 13.15.5 Ceva Santé Animale Latest Developments
  • 13.16 Pulike Biological Engineering,Inc.
    • 13.16.1 Pulike Biological Engineering,Inc. Company Information
    • 13.16.2 Pulike Biological Engineering,Inc. Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.16.3 Pulike Biological Engineering,Inc. Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.16.4 Pulike Biological Engineering,Inc. Main Business Overview
    • 13.16.5 Pulike Biological Engineering,Inc. Latest Developments
  • 13.17 Wuhan Hvsen Biotechnology CO.,LTD
    • 13.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
    • 13.17.2 Wuhan Hvsen Biotechnology CO.,LTD Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.17.3 Wuhan Hvsen Biotechnology CO.,LTD Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.17.4 Wuhan Hvsen Biotechnology CO.,LTD Main Business Overview
    • 13.17.5 Wuhan Hvsen Biotechnology CO.,LTD Latest Developments
  • 13.18 Jinhe Biotechnology Co., Ltd.
    • 13.18.1 Jinhe Biotechnology Co., Ltd. Company Information
    • 13.18.2 Jinhe Biotechnology Co., Ltd. Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.18.3 Jinhe Biotechnology Co., Ltd. Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.18.4 Jinhe Biotechnology Co., Ltd. Main Business Overview
    • 13.18.5 Jinhe Biotechnology Co., Ltd. Latest Developments
  • 13.19 Shanghai Shen Lian Biomedical Corporation
    • 13.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
    • 13.19.2 Shanghai Shen Lian Biomedical Corporation Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.19.3 Shanghai Shen Lian Biomedical Corporation Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.19.4 Shanghai Shen Lian Biomedical Corporation Main Business Overview
    • 13.19.5 Shanghai Shen Lian Biomedical Corporation Latest Developments
  • 13.20 Qingdao Vland Biotech INC.
    • 13.20.1 Qingdao Vland Biotech INC. Company Information
    • 13.20.2 Qingdao Vland Biotech INC. Animal Genetic Engineering Vaccines Product Portfolios and Specifications
    • 13.20.3 Qingdao Vland Biotech INC. Animal Genetic Engineering Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
    • 13.20.4 Qingdao Vland Biotech INC. Main Business Overview
    • 13.20.5 Qingdao Vland Biotech INC. Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Animal Genetic Engineering Vaccines. Industry analysis & Market Report on Animal Genetic Engineering Vaccines is a syndicated market report, published as Global Animal Genetic Engineering Vaccines Market Growth 2023-2029. It is complete Research Study and Industry Analysis of Animal Genetic Engineering Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,829.18
5,658.36
3,407.46
6,814.92
558,845.40
1,117,690.80
308,904.00
617,808.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report